ATE449187T1 - Molekulare eigenschaften von nichtkleinzelligem lungenkrebs - Google Patents

Molekulare eigenschaften von nichtkleinzelligem lungenkrebs

Info

Publication number
ATE449187T1
ATE449187T1 AT02794901T AT02794901T ATE449187T1 AT E449187 T1 ATE449187 T1 AT E449187T1 AT 02794901 T AT02794901 T AT 02794901T AT 02794901 T AT02794901 T AT 02794901T AT E449187 T1 ATE449187 T1 AT E449187T1
Authority
AT
Austria
Prior art keywords
sage
small cell
gene expression
lung cancer
normal
Prior art date
Application number
AT02794901T
Other languages
English (en)
Inventor
Mariana Nacht
Tatiana Dracheva
David Sidransky
Stephen L Madden
Jin Jen
Original Assignee
Us Health
Genzyme Corp
Univ Johns Hopkins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health, Genzyme Corp, Univ Johns Hopkins filed Critical Us Health
Application granted granted Critical
Publication of ATE449187T1 publication Critical patent/ATE449187T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02794901T 2001-08-16 2002-08-16 Molekulare eigenschaften von nichtkleinzelligem lungenkrebs ATE449187T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31240001P 2001-08-16 2001-08-16
PCT/US2002/026027 WO2003015613A2 (en) 2001-08-16 2002-08-16 Molecular characteristics of non-small cell lung cancer

Publications (1)

Publication Number Publication Date
ATE449187T1 true ATE449187T1 (de) 2009-12-15

Family

ID=23211260

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02794901T ATE449187T1 (de) 2001-08-16 2002-08-16 Molekulare eigenschaften von nichtkleinzelligem lungenkrebs

Country Status (8)

Country Link
US (2) US7332590B2 (de)
EP (1) EP1453977B1 (de)
JP (1) JP2005503145A (de)
AT (1) ATE449187T1 (de)
AU (1) AU2002355963A1 (de)
CA (1) CA2456334A1 (de)
DE (1) DE60234467D1 (de)
WO (1) WO2003015613A2 (de)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005503145A (ja) * 2001-08-16 2005-02-03 ザ ユナイテッド ステイツ オブ アメリカ リプレゼンティッド バイ ザ シークレタリー デパートメント オブ ヘルス アンド ヒューマン サービシーズ 非小細胞肺癌の分子特性
ATE331044T1 (de) * 2003-03-04 2006-07-15 Pamgene Bv Verfahren zur integrierten integritätsbewertung und analyse von nukleinsäuren
GB0307428D0 (en) 2003-03-31 2003-05-07 Medical Res Council Compartmentalised combinatorial chemistry
GB0307403D0 (en) 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
US20060078893A1 (en) 2004-10-12 2006-04-13 Medical Research Council Compartmentalised combinatorial chemistry by microfluidic control
JP4724657B2 (ja) * 2003-05-30 2011-07-13 アストラゼネカ ユーケー リミテッド プロセス
EP3305919A1 (de) * 2003-06-10 2018-04-11 The Trustees of Boston University Nachweismethoden für lungenerkrankungen
US20060003391A1 (en) * 2003-08-11 2006-01-05 Ring Brian Z Reagents and methods for use in cancer diagnosis, classification and therapy
CA2540894A1 (en) * 2003-10-03 2005-04-14 Bayer Pharmaceuticals Corporation Gene expression profiles and methods of use
ATE496142T1 (de) 2004-03-23 2011-02-15 Oncotherapy Science Inc Verfahren zur diagnose von nicht-kleinzelligem lungenkrebs
US20050221339A1 (en) 2004-03-31 2005-10-06 Medical Research Council Harvard University Compartmentalised screening by microfluidic control
US7968287B2 (en) 2004-10-08 2011-06-28 Medical Research Council Harvard University In vitro evolution in microfluidic systems
WO2006056080A1 (en) * 2004-11-29 2006-06-01 Diagnocure Inc. Gpx2 a specific and sensitive target for lung cancer diagnosis, prognosis and/or theranosis
US20100035244A1 (en) 2005-04-14 2010-02-11 The Trustees Of Boston University Diagnostic for lung disorders using class prediction
US7504225B2 (en) 2005-05-12 2009-03-17 Applied Genomics, Inc. Reagents and methods for use in cancer diagnosis, classification and therapy
KR100710462B1 (ko) 2005-08-24 2007-04-24 광주과학기술원 폐암 진단용 퍼옥시레독신-ｉ자가항체 마커 및 이를 이용한진단키트
JP2009536313A (ja) 2006-01-11 2009-10-08 レインダンス テクノロジーズ， インコーポレイテッド ナノリアクターの形成および制御において使用するマイクロ流体デバイスおよび方法
WO2007103541A2 (en) 2006-03-09 2007-09-13 The Trustees Of Boston University Diagnostic and prognostic methods for lung disorders using gene expression profiles from nose epithelial cells
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
ATE540750T1 (de) 2006-05-11 2012-01-15 Raindance Technologies Inc Mikrofluidische vorrichtung und verfahren
EP3536396B1 (de) 2006-08-07 2022-03-30 The President and Fellows of Harvard College Fluorkohlenstoffemulsionsstabilisierende tenside
EA010352B1 (ru) * 2006-10-09 2008-08-29 Институт Молекулярной Генетики Российской Академии Наук (Имг Ран) Способ дифференциального анализа протеомов
US8772046B2 (en) 2007-02-06 2014-07-08 Brandeis University Manipulation of fluids and reactions in microfluidic systems
US8592221B2 (en) 2007-04-19 2013-11-26 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
JP2010538680A (ja) 2007-09-19 2010-12-16 ザ トラスティーズ オブ ボストン ユニバーシティー 肺疾患に対する薬剤開発のための新規経路の同定
JP5583117B2 (ja) * 2008-05-14 2014-09-03 ユニバーシティー ヘルス ネットワーク 非小細胞肺癌およびアジュバント化学療法に関する予後診断的および予測的な遺伝子シグネチャー
EP2145964A1 (de) * 2008-07-17 2010-01-20 Universität Zu Köln Verfahren zur Früherkennung und Prognose von Lungenkrebs
EP2315629B1 (de) 2008-07-18 2021-12-15 Bio-Rad Laboratories, Inc. Tröpfchenbibliotheken
US12038438B2 (en) 2008-07-18 2024-07-16 Bio-Rad Laboratories, Inc. Enzyme quantification
US10236078B2 (en) 2008-11-17 2019-03-19 Veracyte, Inc. Methods for processing or analyzing a sample of thyroid tissue
US9495515B1 (en) 2009-12-09 2016-11-15 Veracyte, Inc. Algorithms for disease diagnostics
CN102341709A (zh) * 2009-03-04 2012-02-01 霍夫曼-拉罗奇有限公司 作为肺鳞状细胞癌标志物的丝氨酸蛋白酶抑制蛋白b13
EP3415235B1 (de) 2009-03-23 2025-11-12 Bio-Rad Laboratories, Inc. Manipulation von mikrofluidiktröpfchen
US8669057B2 (en) 2009-05-07 2014-03-11 Veracyte, Inc. Methods and compositions for diagnosis of thyroid conditions
WO2011042564A1 (en) 2009-10-09 2011-04-14 Universite De Strasbourg Labelled silica-based nanomaterial with enhanced properties and uses thereof
EP2493916B1 (de) * 2009-10-26 2016-06-08 Externautics S.p.A. Marker für lungentumore und deren verwendung
CA2780633C (en) 2009-11-13 2019-06-11 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Diazeniumdiolated compounds, pharmaceutical compositions, and method of treating cancer
EP2517025B1 (de) 2009-12-23 2019-11-27 Bio-Rad Laboratories, Inc. Verfahren zur reduzierung des austauschs von molekülen zwischen tröpfchen
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
CA2789425C (en) 2010-02-12 2020-04-28 Raindance Technologies, Inc. Digital analyte analysis with polymerase error correction
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
WO2012045012A2 (en) 2010-09-30 2012-04-05 Raindance Technologies, Inc. Sandwich assays in droplets
EP3859011A1 (de) 2011-02-11 2021-08-04 Bio-Rad Laboratories, Inc. Verfahren zur bildung gemischter tröpfchen
EP3736281A1 (de) 2011-02-18 2020-11-11 Bio-Rad Laboratories, Inc. Zusammensetzungen und verfahren für molekulare etikettierung
US8841071B2 (en) 2011-06-02 2014-09-23 Raindance Technologies, Inc. Sample multiplexing
EP3709018A1 (de) 2011-06-02 2020-09-16 Bio-Rad Laboratories, Inc. Mikrofluidische vorrichtung zum nachweis von komponenten einer chemischen reaktion
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
EP3495817B1 (de) 2012-02-10 2024-10-16 Bio-Rad Laboratories, Inc. Molekulardiagnostischer screeningtest
EP3524693A1 (de) 2012-04-30 2019-08-14 Raindance Technologies, Inc. Digitale analytanalyse
EP3626308A1 (de) 2013-03-14 2020-03-25 Veracyte, Inc. Verfahren zur bewertung eines copd-status
US11976329B2 (en) 2013-03-15 2024-05-07 Veracyte, Inc. Methods and systems for detecting usual interstitial pneumonia
EP2986762B1 (de) 2013-04-19 2019-11-06 Bio-Rad Laboratories, Inc. Digitale analyse von analyten
WO2015042454A1 (en) * 2013-09-20 2015-03-26 Integrated Diagnostics, Inc. Compositions, methods and kits for diagnosis of lung cancer
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US9944977B2 (en) 2013-12-12 2018-04-17 Raindance Technologies, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
US11193176B2 (en) 2013-12-31 2021-12-07 Bio-Rad Laboratories, Inc. Method for detecting and quantifying latent retroviral RNA species
US9594085B2 (en) 2014-02-03 2017-03-14 Integrated Diagnostics, Inc. Integrated quantification method for protein measurements in clinical proteomics
US12297505B2 (en) 2014-07-14 2025-05-13 Veracyte, Inc. Algorithms for disease diagnostics
EP3215170A4 (de) 2014-11-05 2018-04-25 Veracyte, Inc. Systeme und verfahren zur diagnose von idiopathischer pulmonaler fibrose auf transbronchialen biopsien mit maschinellem lernen und hochdimensionalen transkriptionsdaten
CN105154542B (zh) * 2015-09-01 2018-04-17 杭州源清生物科技有限公司 一组用于肺癌分子分型的基因及其应用
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions
EP4180531A3 (de) 2016-05-12 2023-08-23 Trustees of Boston University Genexpressionssignatur des nasenepithels und klassifikator zur vorhersage von lungenkrebs
US10927417B2 (en) 2016-07-08 2021-02-23 Trustees Of Boston University Gene expression-based biomarker for the detection and monitoring of bronchial premalignant lesions
US10998178B2 (en) 2017-08-28 2021-05-04 Purdue Research Foundation Systems and methods for sample analysis using swabs
JP2022527972A (ja) * 2019-04-02 2022-06-07 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 前悪性病変を有する患者において癌を予測及び予防する方法
CN116144778A (zh) * 2023-02-16 2023-05-23 广东省人民医院 利用肠道菌区分晚期突变型和野生型非小细胞肺癌的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4445990A (en) * 1981-11-12 1984-05-01 General Electric Company Electrolytic reactor for cleaning wastewater
US5763165A (en) * 1994-03-10 1998-06-09 Ludwig Institute For Cancer Research Method for determining lung adenocarcinomas by assaying for one or more of MAGE-1, MAGE-2 and MAGE-3
US6087102A (en) * 1998-01-07 2000-07-11 Clontech Laboratories, Inc. Polymeric arrays and methods for their use in binding assays
WO1999050278A1 (en) * 1998-03-31 1999-10-07 Genzyme Corporation Compositions and methods for the identification of lung tumor cells
WO1999060160A1 (en) 1998-05-21 1999-11-25 Diadexus Llc A novel method of diagnosing, monitoring, and staging lung cancer
US20030065157A1 (en) * 2001-04-04 2003-04-03 Lasek Amy W. Genes expressed in lung cancer
JP2005503145A (ja) * 2001-08-16 2005-02-03 ザ ユナイテッド ステイツ オブ アメリカ リプレゼンティッド バイ ザ シークレタリー デパートメント オブ ヘルス アンド ヒューマン サービシーズ 非小細胞肺癌の分子特性
US20060151337A1 (en) * 2005-01-07 2006-07-13 Gilmore F W Electrocoagulation Reaction Chamber

Also Published As

Publication number Publication date
US7332590B2 (en) 2008-02-19
WO2003015613A3 (en) 2004-06-24
EP1453977A2 (de) 2004-09-08
EP1453977A4 (de) 2005-04-20
EP1453977B1 (de) 2009-11-18
WO2003015613A2 (en) 2003-02-27
US20090270265A1 (en) 2009-10-29
AU2002355963A1 (en) 2003-03-03
DE60234467D1 (de) 2009-12-31
JP2005503145A (ja) 2005-02-03
US7709202B2 (en) 2010-05-04
CA2456334A1 (en) 2003-02-27
US20050136403A1 (en) 2005-06-23

Similar Documents

Publication Publication Date Title
ATE449187T1 (de) Molekulare eigenschaften von nichtkleinzelligem lungenkrebs
Anglani et al. Loss of connectivity in cancer co-expression networks
Bittner et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling
Yanagisawa et al. Proteomic patterns of tumour subsets in non-small-cell lung cancer
Zorn et al. Choice of normal ovarian control influences determination of differentially expressed genes in ovarian cancer expression profiling studies
Servant et al. Search for a gene expression signature of breast cancer local recurrence in young women
US7247426B2 (en) Classifying cancers
Sidransky et al. Serum protein MALDI profiling to distinguish upper aerodigestive tract cancer patients from control subjects
Giuliani et al. Epigenetic variability across human populations: a focus on DNA methylation profiles of the KRTCAP3, MAD1L1 and BRSK2 genes
EP1980629A3 (de) Erkennung einer erbb2-Gen-Expressions-Signatur bei Brustkrebs
US20220165363A1 (en) De novo compartment deconvolution and weight estimation of tumor tissue samples using decoder
Rao et al. Laser capture microdissection: a gear for pancreatic cancer research
van Dijk et al. Histone modification patterns using RPPA‐based profiling predict outcome in acute myeloid leukemia patients
Peng et al. Construction and validation of an immune infiltration-related gene signature for the prediction of prognosis and therapeutic response in breast cancer
Herold et al. Biosensors and molecular technologies for cancer diagnostics
Guimarães et al. Molecular profiling of osteosarcoma in children and adolescents from different age groups using a next-generation sequencing panel
Becker et al. Clinical proteomics: new trends for protein microarrays
Tekkela et al. Spatial transcriptomics in human skin research
Sanz-Pamplona et al. A taxonomy of organ-specific breast cancer metastases based on a protein–protein interaction network
Robles et al. KRT81 miR-SNP rs3660 is associated with risk and survival of NSCLC
Feng et al. Comprehensive gene cluster analysis of head and neck squamous cell carcinoma TCGA RNA‐seq data defines B cell immunity‐related genes as a robust survival predictor
Hu et al. The histologic classifications of lung adenocarcinomas are discriminable by unique lineage backgrounds
Stolf et al. Class distinction between follicular adenomas and follicular carcinomas of the thyroid gland on the basis of their signature expression
Callegari‐Jacques et al. Genetic variation within two linguistic Amerindian groups: relationship to geography and population size
Suzuki et al. Aberrant methylation: common in thymic carcinomas, rare in thymomas

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties